Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

143.33 -1.03 (-0.71%)
Streaming Delayed Price Updated: 11:39 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina Inc

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
29 30 Next >
Promising Developments in Breast Cancer Treatments Ahead in 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 12, 2022 – USA News Group – So far in 2022, there have already been some impressive developments in the battle against... 
Via FinancialNewsMedia
Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022
Upgrades Citigroup upgraded the previous rating for Solo Brands Inc (NYSE: 
Via Benzinga
Analyst Ratings For Illumina
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following ... 
Via Benzinga
Illumina Partners With Agendia to Expand Genomic Testing in Breast Cancer Care
SOURCE: Illumina 
Via 3BL Media
48 Biggest Movers From Yesterday
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT... 
Via Benzinga
Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook
Piper says Pacific Bio has a new competitor in Illumina amid plans to launch what looks like a consumable allowing long-read sequencing on its analyzers. 
Via Talk Markets
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year.... 
Via Benzinga
Illumina Announces New Innovative Partnerships, Along With New Groundbreaking Technologies at 2022 J.P. Morgan Healthcare Conference
SOURCE: Illumina 
Via 3BL Media
$100 Invested In This Stock 5 Years Ago, Would Be Worth This Much
Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 3.83% on an annualized basis. Buying $100 In ILMN: 5 years ago, an investor could have purchased 0.62... 
Via Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo... 
Via Benzinga
Why Are Illumina Shares Trading Higher Today?
At the J.P. Morgan Healthcare Conference, Illumina Inc (NASDAQ: ILMN) said it expects about $4.517 billion, +39% Y/Y in 2021 revenue after the company logged... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc cut the price target for Netflix, Inc. (NASDAQ: 
Via Benzinga
21 Stocks Moving in Tuesday's Pre-Market Session
Gainers OneSmart International Education Group Limited (NYSE: ONE) rose 39.1% to $0.2701 in pre-market trading. OneSmart International Education Group received notification from... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Powell
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped more than 160 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
5 Stocks To Watch For January 11, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects TD SYNNEX Corporation (NYSE: SNX) to report quarterly earnings at $2.67 per share on revenue of $... 
Via Benzinga
Start Of The Week
British property (real estate) stocks fell today. 
Via Talk Markets
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Inari Medical (NASDAQ:NARI) stock... 
Via Benzinga
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
From Agendia, Inc.
Via Business Wire
Knight Cancer Institute at Oregon Health & Science University to Offer the Galleri® Multi-Cancer Early Detection Test
From GRAIL, LLC
Via Business Wire
GRAIL and Premier’s PINC AI™ Partner to Support Patient Access to Galleri® Multi-Cancer Early Detection Blood Test
From GRAIL, LLC
Via Business Wire
Illumina Donates Over $14 Million to Local Communities and Volunteers More Than 6,000 Hours in 2021
SOURCE: Illumina 
Via 3BL Media
Why Jim Cramer Likes Illumina And Enterprise Products Partners
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE: 
Via Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating... 
Via Benzinga
Illumina Enters Co-Development Partnership with SomaLogic to Help Researchers’ Understanding of Biology and Disease
SOURCE: Illumina 
Via 3BL Media
Illumina CEO Reflects on the State of Genomics in 2021
SOURCE: Illumina 
Via 3BL Media
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
Illumina Supports Norway's Pioneering Precision Medicine Study
SOURCE: Illumina 
Via 3BL Media
Gretel and Illumina Partner to Develop Synthetic Data for Genomic Research
From Gretel
Via Business Wire
Amid Pandemic, Illumina Invests in 'Culture of Care'
SOURCE: Illumina 
Via 3BL Media
Topics Supply Chain
Exposures COVID-19 Supply Chain
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.